The Ibogaine Conversation Part 4 | The Western world cannot receive the benefits of iboga if they don’t try to understand and assimilate the traditional approach.

The Ibogaine Conversation Part 3 | What is the authentic Bwiti tradition? The answer I got was that this idea of authenticity is an odd idea. It’s a very Western idea. Bwiti considers itself as a culture that’s changing.

The Ibogaine Conversation Part 2 | Our first stop is in Gabon, Africa, where consumption of the iboga root bark is intimately tied to the ancient spiritual discipline known as Bwiti.

The Ibogaine Conversation Part 1 | This series explores the unique challenges ibogaine presents in how we approach plant medicine, harm reduction, and treatment for addiction, through the lens of ibogaine researchers, providers, patients, and advocates from around the world.

Are these states really similar? Many meditators have answered quite clearly, yes.

A group in Oregon is drafting a ballot initiative for 2020 that would allow individuals to take psilocybin in supervised settings.

For anyone who remembers the Reagan Administration's awesome response to the '80s crack epidemic, the Trump plan may prompt discouraging deja vu.

What is it about psychedelics that has the power to change lives for the better? The answer might lie in the unique ways that psychedelics interact with the brain.

Depression. Anxiety. Addiction. Most everyone of us knows somebody who is battling such a condition. Talk therapies may help, but sometimes they don’t. Antidepressants may help, but sometimes they don’t. Some patients are of the opinion that antidepressants are like “Band-Aids” in the way that they never really tackle the underlying issues of their problems.

The incredible mainstream press microdosing has received has managed to avoid many discussions.

MDMA-assisted psychotherapy gave me the ability to feel compassion and empathy for myself.

Holotropic Breathwork is not just a breath technique. It was conceived as a non-drug way of accessing non-ordinary states of consciousness.

There is an urgent need for cultural humility in psychedelic science in order to prevent it from falling into the same limiting, and often unethical, traps that we see in Western science and medicine.

Cluster headaches to me feel like someone has my eyeball in their fist, steadily putting more and more pressure on it until it threatens to pop like a grape.

I chose to learn Grof’s methods for working therapeutically with LSD and use them in my private life to systematically explore my own mind and the mind of the universe as deeply as possible—73 high-dose sessions over 20 years.

There’s a beauty and sense of wonder that comes from knowing how the world works, and the nature of the psychedelic experience dovetails almost perfectly with that awareness.

First, the entire premise—that Schedule I status is the primary obstacle to research—is flat-out wrong.

Instead of worrying so much about addiction, which tends to correct itself when life becomes tolerable, maybe we should worry more about the sources of emotional suffering.

It’s been 50 years since the last one. The original idea was to hold followups every 10 years. But the war on drugs came along, and they were never held. It’s time to take another look at the current state of the art.

Should these drugs become part of medicine cabinets from San Francisco to America’s heartland, it will be high time to develop drug tests that control for the cultural diversity of this country’s doctors and patients.